Rafferty Asset Management
KALA icon

Rafferty Asset Management’s KALA BIO KALA Stock Holding History

Rafferty Asset Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28
Closed -$21K – 1193
2022
Q2 		$21K Buy
28
+2
+8% +$3.14K ﹤0.01% 1123
2022
Q1 		$88K Buy
26
+10
+63% +$26.2K ﹤0.01% 1179
2021
Q4 		$47K Buy
16
+6
+60% +$27.8K ﹤0.01% 1288
2021
Q3 		$64K Buy
+10
New +$86.3K ﹤0.01% 1250

Other funds holding KALA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rafferty Asset Management's KALA Position: Q3 2022 in Review

Rafferty Asset Management sold out of KALA BIO (KALA) in Q3 2022, closing a stake of 28 shares — an estimated $21K sold.

Rafferty Asset Management first reported a position in KALA in Q3 2021 and held it in 4 quarters. The position peaked at $88K in Q1 2022. 53 funds tracked by Wall St. Rank hold KALA as of Q3 2022.

  • Rafferty Asset Management reported no remaining KALA BIO position as of Q3 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 28 KALA BIO shares in Q3 2022, an estimated $21K.
  • Rafferty Asset Management first reported a position in KALA BIO in Q3 2021 and held it in 4 quarters.
  • Rafferty Asset Management's KALA BIO position peaked at $88K in Q1 2022.
  • 53 funds tracked by Wall St. Rank held KALA BIO as of Q3 2022.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.